Syndax Pharma (SNDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -217,408 | -156,693 | -84,846 | -318,758 | -224,589 |
| Depreciation Amortization | -8,991 | -6,643 | -3,487 | -13,430 | -10,520 |
| Accounts receivable | -52,800 | -11,846 | -8,120 | -11,237 | -5,233 |
| Accounts payable and accrued liabilities | 2,200 | 5,727 | -1,579 | 1,665 | -5,063 |
| Other Working Capital | -67,560 | -44,181 | -17,475 | 12,807 | -14,379 |
| Other Operating Activity | 91,067 | 30,679 | 20,345 | 54,050 | 42,269 |
| Operating Cash Flow | $-253,492 | $-182,957 | $-95,162 | $-274,903 | $-217,515 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 208,589 | 136,029 | 94,142 | -219,775 | 49,198 |
| PPE Investments | -131 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $208,458 | $136,029 | $94,142 | $-219,775 | $49,198 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 343,652 | N/A |
| Common Stock Issued | 7,759 | 1,481 | 930 | 9,715 | 5,942 |
| Financing Cash Flow | $7,759 | $1,481 | $930 | $353,367 | $5,942 |
| Beginning Cash Position | 154,300 | 154,300 | 154,300 | 295,611 | 295,611 |
| End Cash Position | 117,025 | 108,853 | 154,210 | 154,300 | 133,236 |
| Net Cash Flow | $-37,275 | $-45,447 | $-90 | $-141,311 | $-162,375 |
| Free Cash Flow | |||||
| Operating Cash Flow | -253,492 | -182,957 | -95,162 | -274,903 | -217,515 |
| Capital Expenditure | -131 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -253,623 | -182,957 | -95,162 | -274,903 | -217,515 |